Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol

被引:5
|
作者
Yazawa, Masahiko [1 ,2 ,3 ]
Cseprekal, Orsolya [1 ,2 ,4 ]
Helmick, Ryan A. [1 ,2 ]
Talwar, Manish [1 ,2 ]
Balaraman, Vasanthi [1 ,2 ]
Podila, Pradeep S. B. [5 ,6 ]
Agbim, Uchenna A. [1 ,2 ]
Maliakkal, Benedict [1 ,2 ]
Fossey, Sallyanne [7 ]
Satapathy, Sanjaya K. [8 ]
Sumida, Keiichi [9 ]
Kovesdy, Csaba P. [9 ,10 ]
Nair, Satheesh [1 ,2 ]
Eason, James D. [1 ,2 ]
Molnar, Miklos Z. [1 ,2 ,4 ,9 ]
机构
[1] Methodist Univ Hosp, James D Eason Transplant Inst, Memphis, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Div Transplant Surg, Memphis, TN USA
[3] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan
[4] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary
[5] Methodist Le Bonheur Healthcare, Faith & Hlth Div, Memphis, TN USA
[6] Univ Memphis, Sch Publ Hlth, Div Hlth Syst Management & Policy, Memphis, TN 38152 USA
[7] DCI Inc, Transplant Immunol Lab, Nashville, TN USA
[8] Northshore Univ Hosp, Northwell Hlth, Dept Med, Sandra Atlas Bass Ctr Liver Dis & Transplantat, Manhasset, NY USA
[9] Univ Tennessee, Hlth Sci Ctr, Dept Med, Div Nephrol, Memphis, TN USA
[10] Memphis Vet Affairs Med Ctr, Nephrol Sect, Memphis, TN USA
关键词
Pretransplant donor-specific antibody; Donor-specific antibodies; Kidney outcome; Simultaneous liver-kidney transplantation; CROSS-MATCH; MEDIATED REJECTION; SERUM CREATININE; SURVIVAL; DISEASE; ALLOANTIBODIES; PREDICTION; PROSPECTS; MODEL; MELD;
D O I
10.1159/000505460
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction and Objective: The impact of pretransplant donor-specific antibodies (DSAs), especially class II DSAs, on kidney allograft outcomes remains unclear in simultaneous liver-kidney transplantation (SLKT) recipients. Methods: We examined 85 recipients who consecutively underwent SLKT between 2009 and 2018 in our center. Associations between pretransplant DSA and worsening kidney function (WKF), kidney allograft loss, composite kidney outcome (WKF and/or antibody-mediated rejection and/or death-censored kidney allograft loss), death with functioning graft, and overall mortality were examined in survival analysis. WKF was defined as an eGFR decrease of 30% or greater from baseline, or 2 or more episodes of proteinuria, at least 90 days apart from each other. Results: The mean age at SLKT was 56 +/- 10 years, and 62% of the recipients were male. More than one quarter (26%) of our recipients were African American. The 2 major causes of end-stage liver disease were hepatitis C (28%) and alcoholic hepatitis (26%). Nineteen recipients (22%) had pretransplant DSAs at the time of SLKT. The DSA(+) group and DSA(-) group had similar risk of WKF (unadjusted model: hazard ratio [HR] = 0.77, 95% confidence interval [CI]: 0.29-2.05 and adjusted model: HR = 0.36, 95% CI: 0.12-1.08); similar risk of composite kidney outcome (unadjusted model: HR = 1.04, 95% CI: 0.45-2.43 and adjusted model: HR = 0.53, 95% CI: 0.20-1.39); and similar risk of overall death (unadjusted model: HR = 1.23, 95% CI: 0.45-3.36 and adjusted model: HR = 1.28, 95% CI: 0.42-3.87). We found similar results when comparing different DSA subclasses (class I and II DSAs) with recipients without DSAs. Conclusions: The presence of pretransplant DSAs was not associated with worse kidney allograft outcomes from our single-center experience. Further prospective larger studies are strongly warranted.
引用
收藏
页码:126 / 137
页数:12
相关论文
共 9 条
  • [1] Association between post-transplant donor-specific antibodies and recipient outcomes in simultaneous liver-kidney transplant recipients: single-center, cohort study
    Yazawa, Masahiko
    Cseprekal, Orsolya
    Helmick, Ryan A.
    Talwar, Manish
    Balaraman, Vasanthi
    Podila, Pradeep S. B.
    Agbim, Uchenna A.
    Maliakkal, Benedict
    Fossey, Sallyanne
    Satapathy, Sanjaya K.
    Sumida, Keiichi
    Kovesdy, Csaba P.
    Nair, Satheesh
    Eason, James D.
    Molnar, Miklos Z.
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 202 - 215
  • [2] Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver-kidney transplant recipients
    Yazawa, Masahiko
    Cseprekal, Orsolya
    Helmick, Ryan A.
    Talwar, Manish
    Balaraman, Vasanthi
    Podila, Pradeep S. B.
    Fossey, Sallyanne
    Satapathy, Sanjaya K.
    Eason, James D.
    Molnar, Miklos Z.
    RENAL FAILURE, 2020, 42 (01) : 40 - 47
  • [3] Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year
    Taner, Timucin
    Gustafson, Michael P.
    Hansen, Michael J.
    Park, Walter D.
    Bornschlegl, Svetlana
    Dietz, Allan B.
    Stegall, Mark D.
    KIDNEY INTERNATIONAL, 2018, 93 (06) : 1465 - 1474
  • [4] Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients
    Lee, Haeun
    Lee, Hanbi
    Eum, Sang Hun
    Ko, Eun Jeong
    Min, Ji-Won
    Oh, Eun-Jee
    Yang, Chul Woo
    Ha Chung, Byung
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (04) : 364 - 374
  • [5] The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients
    Ankit Sharma
    Anne Taverniti
    Nicole Graf
    Armando Teixeira-Pinto
    Joshua R. Lewis
    Wai H. Lim
    Stephen I. Alexander
    Anne Durkan
    Jonathan C. Craig
    Germaine Wong
    Pediatric Nephrology, 2020, 35 : 1061 - 1068
  • [6] The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients
    Sharma, Ankit
    Taverniti, Anne
    Graf, Nicole
    Teixeira-Pinto, Armando
    Lewis, Joshua R.
    Lim, Wai H.
    Alexander, Stephen, I
    Durkan, Anne
    Craig, Jonathan C.
    Wong, Germaine
    PEDIATRIC NEPHROLOGY, 2020, 35 (06) : 1061 - 1068
  • [7] Association of Circulating Anti-HLA Donor-Specific Antibodies and Their Characteristics, including C1q-Binding Capacity, in Kidney Transplant Recipients with Long-Term Renal Graft Outcomes
    Gniewkiewicz, Michal
    Czerwinska, Katarzyna
    Zielniok, Katarzyna
    Durlik, Magdalena
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [8] Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes
    Gniewkiewicz, Michal
    Czerwinska, Katarzyna
    Zielniok, Katarzyna
    Durlik, Magdalena
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
  • [9] Association Between De Novo C1q-Binding Donor-Specific Anti-HLA Antibodies and Clinical Outcomes After Kidney Transplantation: A Meta-Analysis
    Rasyid, Nur
    Duarsa, Gede Wirya Kusuma
    Tirtayasa, Pande Made Wisnu
    Situmorang, Gerhard Reinaldi
    Rodjani, Arry
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (09) : 1976 - 1983